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Objectives
Although meta-analyses are typically viewed as retro-
spective activities, they are increasingly being applied
prospectively to justify planned research by providing
up-to-date evidence on specific research questions.
Since healthcare policy makers often base decisions on
systematic reviews of reliable evidence rather than on
single clinical trials, trialists should consider planning
additional research with regard to the meta-analytic
result.
Since adding a new study to an existing meta-analysis
creates a multiple testing scenario, which standard
methods do not well address, nominal significance levels
need to be adjusted to preserve the overall type-I error
rate. Sequential approaches to meta-analysis have been
proposed, although these do not lead directly to recom-
mendations on planning new studies.
Methods
We propose to use the framework of adaptive clinical
trial design methods to plan studies for addition to a
meta-analysis.
Results
We discuss the implementation of the adaptive method
proposed by Bauer and Köhne (1994) to the meta-analy-
sis framework, and discuss the implications of heteroge-
neity among studies when applying them to a random-
effects meta-analysis.
By additionally deriving the conditional power of a
random-effects meta-analysis under different assump-
tions (about the number of additional studies, their
information sizes and of the heterogeneity anticipated
among them), we can assess the impact of new trials on
the meta-analysis. For instance, if heterogeneity is
anticipated, it might not be possible for a single study to
reach the desirable power no matter how large it is.
Simple graphs that summarize the conditional powers of
possible design alternatives provide a convenient way to
explore different strategies for planning research.
We illustrate this framework for designing new trials
for different scenarios using data from the Cochrane
Database of Systematic Reviews.
Conclusions
We provide a framework for designing new trials with
regard to the meta-analytic result rather than the study
in isolation.
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